Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Cognition Disorders (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cognition Disorders (diet therapy) < Cognition Disorders (drug therapy) < Cognition Disorders (economics)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000297 (2000) J. Kulisevsky [Espagne] ; C. García-Sánchez ; M L Berthier ; M. Barbanoj ; B. Pascual-Sedano ; A. Gironell ; A. Estévez-GonzálezChronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients.
000631 (2001) P J Reading [Royaume-Uni] ; A K Luce ; I G MckeithRivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial.
000878 (2002) Drugs to treat dementia and psychosis: management of Parkinson's disease.
000B92 (2003) James T H. Yip [République populaire de Chine] ; Tatia M C. Lee ; Shu-Leong Ho ; Kin-Lun Tsang ; Leonard S W. LiEmotion recognition in patients with idiopathic Parkinson's disease.
000F81 (2004) Giovanni Cossu [Italie] ; Maurizio Melis ; Giannina Melis ; Elisabetta Maccioni ; Valeria Putzu ; Olga Catte ; Paolo Francesco PutzuReversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
002189 (2008) Wendy Phillips [Royaume-Uni] ; Kathleen M. Shannon ; Roger A. BarkerThe current clinical management of Huntington's disease.
002442 (2009) Laura Marsh [États-Unis] ; Kevin Biglan [États-Unis] ; Melissa Gerstenhaber [États-Unis] ; James R. Williams [États-Unis]Atomoxetine for the treatment of executive dysfunction in Parkinson’s disease
002777 (2009) Karim Farid [France] ; Igor Sibon ; Dominique Guehl ; Emmanuel Cuny ; Pierre Burbaud ; Michèle AllardBrain dopaminergic modulation associated with executive function in Parkinson's disease.
002856 (2009) Adrienne Curtis [Royaume-Uni] ; Ian Mitchell ; Smitaa Patel ; Natalie Ives ; Hugh RickardsA pilot study using nabilone for symptomatic treatment in Huntington's disease.
002875 (2009) Jane E. Alty [Australie] ; Benjamin G. Clissold ; Craig D. Mccoll ; Katrina A. Reardon ; Mark Shiff ; Peter A. KempsterLongitudinal study of the levodopa motor response in Parkinson's disease: relationship between cognitive decline and motor function.
003149 (2011) Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit ; P Nar Unsalan ; Hilal Horozoglu ; Nese Tuncer ; Aynur Feyzioglu ; Dilek Ince Gunal ; Gorsev G. Yener ; Raif Cakmur ; Huseyin A. Sahin ; Murat EmreThe effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.
003193 (2011) Dimitrios Kapogiannis [États-Unis] ; Eric Mooshagian [États-Unis] ; Paul Campion [États-Unis] ; Jordan Grafman [États-Unis] ; Trelawny J. Zimmermann [États-Unis] ; Kelsey C. Ladt [États-Unis] ; Eric M. Wassermann [États-Unis]Reward processing abnormalities in Parkinson disease
003429 (2012) Charles S. Venuto [États-Unis] ; Andrew Mcgarry ; Qing Ma ; Karl KieburtzPharmacologic approaches to the treatment of Huntington's disease.
003443 (2011) Klaus Seppi [Autriche] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease
003C44 (2013) Fabrizio Stocchi [Italie] ; Olivier Rascol ; Alain Destée [France] ; Nobutaka Hattori ; Robert A. Hauser ; Anthony E. Lang ; Werner Poewe [Autriche] ; Mark Stacy ; Eduardo Tolosa ; Haitao Gao ; Jennifer Nagel ; Martin Merschhemke ; Ana Graf ; Christopher Kenney ; Claudia TrenkwalderAFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
003D48 (2013) David E. Vaillancourt [États-Unis] ; Daniel Schonfeld [États-Unis] ; Youngbin Kwak [États-Unis] ; Nicolaas I. Bohnen [États-Unis] ; Rachael Seidler [États-Unis]Dopamine overdose hypothesis: Evidence and clinical implications
004136 (2015) Ji Hyun Ko [États-Unis] ; Renata P. Lerner ; David EidelbergEffects of levodopa on regional cerebral metabolism and blood flow.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Cognition Disorders (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Cognition Disorders (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Cognition Disorders (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024